Scientific/Clinical Member Nominations Are Now Being Accepted for the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents with HIVThe Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents (or the Panel) is accepting nominations for new scientific/clinical members with expertise in HIV medicine. The Panel is seeking candidates with expertise in antiretroviral therapy and the following areas:
- HIV clinical research and clinical care
- Hepatitis B and hepatitis C infections
- Cost effectiveness and resource utilization
- Clinical pharmacology (with emphasis on drug-drug interactions)
The Panel is a Working Group of the Office of AIDS Research Advisory Council of the National Institutes of Health. The Panel is composed of over 40 members who are clinicians, researchers, academicians, HHS representatives, and community representatives with expertise in HIV management in the United States. The Panel meets monthly via teleconferencing and annually in a face-to-face meeting to review and critically evaluate emerging scientific data relating to antiretroviral therapy and to revise the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. The latest guideline was published on October 25, 2018, and can be found at https://aidsinfo.nih.gov/.
Panel members are not financially compensated for their time commitment.
The nomination should include a curriculum vitae and a letter of interest or a letter of nomination (from a colleague) with specific reference to how the nominee would contribute to the work of the Panel, especially in the areas noted above. Self-nomination is welcome. All supporting documents should be submitted to Alice Pau, Pharm.D., electronically (firstname.lastname@example.org) by no later than January 15, 2019.